ZYNERBA PHARMACEUTICALS
Zynerba Pharmaceuticals is dedicated to the development of innovative transdermal cannabinoid treatments for patients with high unmet medical needs using modern drug delivery technology and appropriate regulatory pathways. Zynerba is developing two therapeutic candidates based on proprietary transdermal technologies that, if successfully developed, may allow sustained, consistent and controlled delivery of therapeutic levels of cannabinoids. Transdermal delivery reduces adverse effects associate... d with oral dosing. ZYN001 will be studied in fibromyalgia, neuropathic pain and chronic cancer pain utilizing a synthetically manufactured prodrug of THC in a transdermal patch to deliver THC through the skin and into the bloodstream. Zynerba expects to initiate ZYN001 Phase 1 clinical studies in 2Q 2015. ZYN002 will be studied in epilepsy and rheumatoid arthritis, utilizing a proprietary gel to deliver synthetically manufactured cannabidiol (CBD), a non-psychotropic cannabinoid, through the skin and into the bloodstream. Zynerba expects to initiate ZYN002 Phase 1 clinical studies in 3Q 2015. Learn more at www.zynerba.com and follow the company on Twitter at @ZynerbaPharma.
ZYNERBA PHARMACEUTICALS
Industry:
Biotechnology Developer Tools Pharmaceutical Product Design
Founded:
2007-01-01
Address:
Devon, Pennsylvania, United States
Country:
United States
Website Url:
http://www.zynerba.com
Total Employee:
1+
Status:
Active
Contact:
+1 484 581 7505
Total Funding:
13 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics
Similar Organizations
Innovus Pharmaceuticals
Innovus Pharmaceuticals develops healthcare products for dermatology, autoimmune, respiratory, and sexual dysfunction diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Perceptive Advisors
Perceptive Advisors investment in Venture Round - Zynerba Pharmaceuticals
Keyhorse Capital (KSTC)
Keyhorse Capital (KSTC) investment in Seed Round - Zynerba Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-15 | Zynerba Pharmaceuticals Names New CLO & Corporate Secretary |
Official Site Inspections
http://www.zynerba.com Semrush global rank: 1.81 M Semrush visits lastest month: 12.59 K
- Host name: 201.102.198.104.bc.googleusercontent.com
- IP address: 104.198.102.201
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
